Dr. Guidon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
165 Cambridge St
Boston, MA 02114Phone+1 617-724-6387Fax+1 617-726-2019- Is this information wrong?
Education & Training
Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2012 - 2013- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
- Duke University HospitalResidency, Neurology, 2008 - 2011
- Duke University HospitalInternship, Internal Medicine, 2007 - 2008
University of Rochester School of Medicine and DentistryClass of 2007
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2013 - 2025
NC State Medical License 2007 - 2014- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- American Board of Electrodiagnostic Medicine (ABEM)
Publications & Presentations
PubMed
- 2 citationsNeurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.Farina, A., Villagrán-García, M., Vogrig, A., Muñiz-Castrillo, S., Velasco, R., Joubert, B., Honnorat, J., Zekeridou, A., Guidon, A.> ;The Lancet. Neurology. 2024 Jan 1
- Implementation of a myasthenia gravis drug-disease interaction clinical decision support tool reduces prescribing of high-risk medications.Megan E Barra, Andrew J Webb, Russel J Roberts, Marjorie Ross, Robert Hallisey, Paul Szumita, Amanda C Guidon> ;Muscle & Nerve. 2023 Apr 1
- Safety and outcomes of eculizumab for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.Joome Suh, Virginia Clarke, Anthony A Amato, Amanda C Guidon> ;Muscle & Nerve. 2022 Sep 1
- Join now to see all
Press Mentions
“Chemical Plasmapheresis” Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 TrialJuly 11th, 2019
Myasthenia Gravis: Framingham Resident Lives with Rare DiseaseJune 24th, 2019
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
